{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:19:36Z","timestamp":1787552376143,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol. Rev."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Brucea javanica oil emulsion (BJOE) has been proposed as an adjuvant therapy to mitigate adverse reactions in cervical cancer patients receiving radiotherapy\/chemotherapy, yet its efficacy remains understudied. This meta-analysis aimed to systematically evaluate the clinical benefits and safety of BJOE in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched PubMed, Embase, Cochrane Library, and six other databases for Randomized controlled trials (RCTs) up to February 2025. Primary outcomes included adverse reactions (rectal symptoms, nausea\/vomiting, leukopenia, radiation cystitis) and immune function markers (CD3\n                      <jats:sup>+<\/jats:sup>\n                      , CD4\n                      <jats:sup>+<\/jats:sup>\n                      , CD8\n                      <jats:sup>+<\/jats:sup>\n                      ). Pooled risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CIs) were calculated using RevMan 5.4 and Stata 13.0.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five RCTs (N = 372 patients) were included. BJOE supplementation significantly reduced the incidence of rectal symptoms (RR = 0.56, 95%CI: 0.45\u20130.68), nausea\/vomiting (RR = 0.60, 95%CI: 0.43\u20130.85), leukopenia (RR = 0.52, 95%CI: 0.34\u20130.77), and radiation cystitis (RR = 0.46, 95%CI: 0.33\u20130.63). Immune function improved markedly (CD3+: MD = 4.42, 95%CI: 3.76\u20135.08; CD4+: MD = 2.50, 95%CI: 1.88\u20133.13; CD8+: MD = 3.14, 95%CI: 1.84\u20134.43).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As an adjunctive rather than a direct antitumor agent, BJOE effectively reduces treatment-related adverse effects and enhances immune responses in patients with cervical cancer undergoing chemoradiotherapy, supporting its clinical utility. However, the current evidence grades predominantly fall into the low or very low categories, further large-scale trials are warranted to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/or.2026.1880668","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:29Z","timestamp":1787549489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Brucea javanica oil emulsion as an adjunct to chemoradiotherapy in cervical cancer: a systematic review and meta-analysis of adverse effects reduction and immune enhancement"],"prefix":"10.3389","volume":"20","author":[{"given":"Buwei","family":"Han","sequence":"first","affiliation":[{"name":"School of Pharmacy, Harbin University of Commerce","place":["Harbin, China"]},{"name":"Postdoctoral Scientific Research Workstation, Harbin University of Commerce","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingge","family":"Liang","sequence":"additional","affiliation":[{"name":"Graduate College, Heilongjiang University of Traditional Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Qi","sequence":"additional","affiliation":[{"name":"Graduate College, Heilongjiang University of Traditional Chinese Medicine","place":["Harbin, China"]},{"name":"Gynecological Ward 2, Second Affiliated Hospital of Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Qu","sequence":"additional","affiliation":[{"name":"Graduate College, Heilongjiang University of Traditional Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhe","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guizhou University of Chinese Medicine","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Ai","sequence":"additional","affiliation":[{"name":"Graduate College, Heilongjiang University of Traditional Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Harbin University of Commerce","place":["Harbin, China"]},{"name":"Postdoctoral Scientific Research Workstation, Harbin University of Commerce","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Harbin University of Commerce","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1002\/mco2.368","article-title":"Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions","volume":"4","author":"Ye","year":"2020","journal-title":"MedComm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/01443615.2021.2012437","article-title":"The effect of consolidation chemotherapy after concurrent chemoradiation on the prognosis of locally advanced cervical cancer: a systematic review and meta-analysis","volume":"42","author":"Zhong","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1136\/ijgc-2019-001131","article-title":"Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer","volume":"30","author":"Van Den Akker","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/ijgc-2021-002492","article-title":"Advances in immunotherapy for cervical cancer: recent developments and future directions","volume":"32","author":"Sherer","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1065793","DOI":"10.3389\/fphar.2022.1065793","article-title":"Nanotechnology in cervical cancer immunotherapy: therapeutic vaccines and adoptive cell therapy","volume":"16","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15347354221092706","DOI":"10.1177\/15347354221092706","article-title":"Enhancement of conventional and photodynamic therapy for treatment of cervical cancer with cannabidiol","volume":"21","author":"Razlog","year":"2022","journal-title":"Integr Cancer Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"935155","DOI":"10.3389\/fphar.2022.935155","article-title":"Brucea javanica oil emulsion promotes autophagy in ovarian cancer cells through the miR-8485\/LAMTOR3\/mTOR\/ATG13 signaling axis","volume":"25","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/10837450.2023.2196330","article-title":"Application of a novel multicomponent nanoemulsion to tumor therapy based on the theory of unification of drugs and excipients","volume":"28","author":"Li","year":"2023","journal-title":"Pharm Dev Technol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"853119","DOI":"10.3389\/fphar.2022.853119","article-title":"Major constituents from Brucea javanica and their pharmacological actions","volume":"18","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5306\/wjco.v11.i2.53","article-title":"Objective response rate assessment in oncology: current situation and future expectations","volume":"11","author":"Aykan","year":"2020","journal-title":"World J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using risk of bias 2 to assess results from randomised controlled trials: guidance from cochrane","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making","volume":"129","author":"Brozek","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"B14","first-page":"26","article-title":"Analysis of effects of Brucea javanica oil emulsion injection on treatment of cervical cancer and improvement of adverse reactions of chemoradiotherapy","volume":"20","author":"Peng","year":"2022","journal-title":"J Clin Pharmacother"},{"key":"B15","volume-title":"Clinical Observation of Simultaneous Chemoradiotherapy Combined with Brucea javanica Oil Softgel in the Treatment of Advanced Cervical Cancer [D]","author":"Yang","year":"2016"},{"key":"B16","first-page":"285","article-title":"Nursing analysis of Brucea javanica oil emulsion in alleviating radiation and chemotherapy reaction of cervical cancer","volume":"45","author":"Shang","year":"2016","journal-title":"Chongqing Med"},{"key":"B17","first-page":"1928","article-title":"Clinical observation of Brucea javanica oil emulsion combined with intensity modulated radiotherapy and intracavitary retrofitting in treatment of cervical cancer","volume":"22","author":"Deng","year":"2014","journal-title":"Mod Oncol Med"},{"key":"B18","first-page":"236","article-title":"Clinical observation of intensity modulated radiotherapy combined with brucea javanica oil emulsion injection in the treatment of 28 cases of early cervical cancer","volume":"35","author":"Wu","year":"2013","journal-title":"Hebei Traditional Chin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cance","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.3390\/jcm10214825","article-title":"Cervical cancer and fertility-sparing treatment","volume":"10","author":"Zaccarini","year":"2021","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3390\/cancers15113034","article-title":"Comparison of oncologic outcomes between radical hysterectomy and primary concurrent chemoradiotherapy in women with bulky IB and IIA cervical cancer under risk stratification","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e055765","DOI":"10.1136\/bmjopen-2021-055765","article-title":"Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial","volume":"12","author":"Chopra","year":"2022","journal-title":"BMJ Open"},{"key":"B23","first-page":"67","article-title":"Clinical study of jianpi wenshen ruanjian jiedu formula combined with Kang'ai injection and low-dose chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer of spleen-kidney deficiency pattern","volume":"54","author":"Yao","year":"2020","journal-title":"Shanghai J Traditional Chin Med"},{"key":"B24","first-page":"167","article-title":"Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis","volume":"40","author":"Zhang","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e23197","DOI":"10.1097\/MD.0000000000023197","article-title":"Efficacy and safety of Brucea javanica oil emulsion for liver cancer: a protocol for systematic review and meta-analysis","volume":"99","author":"Luo","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.21037\/tcr.2019.12.62","article-title":"Brucea javanica oil emulsion suppresses tumor growth in human cervical cancer cells through inhibition of the E6 oncogene and induction of apoptosis","volume":"9","author":"Ye","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"998218","DOI":"10.3389\/fphar.2022.998218","article-title":"Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: a meta-analysis of randomized controlled trials","volume":"16","author":"Shi","year":"2022","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"889799","DOI":"10.3389\/fphar.2022.889799","article-title":"Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges","volume":"5","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10717544.2018.1440447","article-title":"Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy","volume":"25","author":"Bi","year":"2018","journal-title":"Drug Deliv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8851","DOI":"10.1038\/s41598-020-65773-9","article-title":"Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo","volume":"10","author":"Huang","year":"2020","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10717544.2016.1233589","article-title":"High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation","volume":"24","author":"Hong","year":"2017","journal-title":"Drug Deliv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.3390\/molecules25225414","article-title":"Medicinal activities and nanomedicine delivery strategies for Brucea javanica oil and its molecular components","volume":"25","author":"Yoon","year":"2020","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12282-025-01819-y","article-title":"Prognostic relevance of specific TIL (CD4+, CD8+, and FOXP3 + T-cell infiltrates) in triple-negative breast cancer: short- and long-term outcomes","volume":"33","author":"Caramelo","year":"2026","journal-title":"Breast Cancer"},{"key":"B34","first-page":"68","article-title":"Peripheral blood IFN-gamma-producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor-based therapy","volume":"6","author":"Wang","year":"2026","journal-title":"Discov Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1002\/cam4.3150","article-title":"Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/bmjebm-2019-111191","article-title":"The magnitude of small-study effects in the cochrane database of systematic reviews: an empirical study of nearly 30 000 meta-analyses","volume":"25","author":"Lin","year":"2020","journal-title":"BMJ Evid Based Med"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1880668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:31Z","timestamp":1787549491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1880668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":36,"alternative-id":["10.3389\/or.2026.1880668"],"URL":"https:\/\/doi.org\/10.3389\/or.2026.1880668","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1880668"}}